Table 3 Vaccine Availability across Measles Vaccine Vial Size Scenarios and Target Population Sizes
Measles Vaccine Vial Size Scenario | 10-doses per vial | 5-doses per vial | 2-doses per vial | 1-doses per vial |
|---|---|---|---|---|
100% Target Population Size | ||||
Bacille Calmette-Guerin Tuberculosis (BCG) | 79% | 79% | 78% | 76% |
Diptheria-tetanus-pertussis-hepatitis B-haemophilus influenza type B (DTP-HepB-Hib) | 84% | 84% | 82% | 80% |
Measles | 90% | 87% | 86% | 80% |
Oral polio (OPV) | 80% | 80% | 78% | 76% |
Tetanus toxoid (TT) | 84% | 84% | 83% | 80% |
Yellow fever (YF) | 79% | 79% | 78% | 76% |
80% Target Population Size | ||||
BCG | 84% | 85% | 85% | 84% |
DTP-HepB-Hib | 86% | 86% | 86% | 84% |
Measles | 94% | 92% | 89% | 84% |
OPV | 80% | 80% | 80% | 79% |
TT | 86% | 86% | 86% | 84% |
YF | 84% | 85% | 85% | 84% |
60% Target Population Size | ||||
BCG | 81% | 81% | 81% | 80% |
DTP-HepB-Hib | 91% | 91% | 91% | 89% |
Measles | 93% | 91% | 91% | 90% |
OPV | 82% | 82% | 82% | 82% |
TT | 90% | 90% | 90% | 89% |
YF | 81% | 81% | 81% | 80% |